Skip to main content
Top
Published in: International Journal of Colorectal Disease 1/2009

01-01-2009 | Original Article

An orthotopic nude mouse model for preclinical research of gastric cardia cancer

Authors: Sarah Bhargava, Birgit Hotz, Heinz J. Buhr, Hubert G. Hotz

Published in: International Journal of Colorectal Disease | Issue 1/2009

Login to get access

Abstract

Purpose

A clinically relevant animal model for cancer of the esophagogastric junction does not exist. This study aimed to establish an orthotopic mouse model for human gastric cancer of the distal stomach and the gastric cardia.

Materials and methods

Human gastric cancer cell lines AGS, MKN-45, and NCI-N87 were injected subcutaneously into nude mice. These donor tumors were harvested after 4 weeks and minced into small tumor fragments. One donor tumor fragment was orthotopically implanted into the submucosa of either gastric cardia or distal stomach in other mice. The animals were killed 4, 8, and 12 weeks after tumor implantation. Volume of the primary tumor and local and systemic tumor spread were determined.

Results

The implantation technique resulted in a tumor take rate of 100%. An artificial dissemination of tumor cells into the abdominal cavity due to the procedure was not observed.

Conclusions

We report for the first time the development of a clinically relevant mouse model for human gastric cancer of the gastric cardia and the distal stomach. Primary tumor growth and local and systemic spread progressed continuously during the observation period and mimic the human situation of this disease. This model may be suitable to evaluate novel treatment strategies for this malignancy.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef
2.
go back to reference Forman D, Burley VJ (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20:633–649PubMedCrossRef Forman D, Burley VJ (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20:633–649PubMedCrossRef
3.
go back to reference Li H, Yao SC (1997) Surgical treatment for carcinomas of the oesophagus in Chinese language publications. Br J Surg 84:855–857PubMedCrossRef Li H, Yao SC (1997) Surgical treatment for carcinomas of the oesophagus in Chinese language publications. Br J Surg 84:855–857PubMedCrossRef
4.
go back to reference Stein HJ, von Rahden BH, Hofler H, Siewert JR (2003) Karzinom des osophagogastralen Ubergangs und Barrett-Osophagus. Ein nahezu klares onkologisches Modell? Chirurg 74:703–708PubMedCrossRef Stein HJ, von Rahden BH, Hofler H, Siewert JR (2003) Karzinom des osophagogastralen Ubergangs und Barrett-Osophagus. Ein nahezu klares onkologisches Modell? Chirurg 74:703–708PubMedCrossRef
5.
go back to reference Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, Schatzkin A (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165:1424–1433PubMedCrossRef Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, Schatzkin A (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165:1424–1433PubMedCrossRef
6.
go back to reference Pera M (2003) Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett’s esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 27:999–1008PubMedCrossRef Pera M (2003) Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett’s esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 27:999–1008PubMedCrossRef
7.
go back to reference Tajima Y, Yamazaki K, Makino R, Nishino N, Masuda Y, Aoki S, Kato M, Morohara K, Kusano M (2007) Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer 96:631–638PubMedCrossRef Tajima Y, Yamazaki K, Makino R, Nishino N, Masuda Y, Aoki S, Kato M, Morohara K, Kusano M (2007) Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer 96:631–638PubMedCrossRef
8.
go back to reference Böttcher KEM, Stein HJ, Roder JD, Siewert JR (1999) Chirurgische Therapie bei Karzinomen des proximalen Magendrittels und des ösophagogastralen Übergangs. Chir Gastroenterol 15:237–243CrossRef Böttcher KEM, Stein HJ, Roder JD, Siewert JR (1999) Chirurgische Therapie bei Karzinomen des proximalen Magendrittels und des ösophagogastralen Übergangs. Chir Gastroenterol 15:237–243CrossRef
9.
go back to reference Siewert JRHAH, Becker K, Gössner W (1987) Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 58:25–32PubMed Siewert JRHAH, Becker K, Gössner W (1987) Cardia cancer: attempt at a therapeutically relevant classification. Chirurg 58:25–32PubMed
10.
go back to reference von Rahden BH, Feith M, Stein HJ (2005) Carcinoma of the cardia: classification as esophageal or gastric cancer? Int J Colorectal Dis 20:89–93CrossRef von Rahden BH, Feith M, Stein HJ (2005) Carcinoma of the cardia: classification as esophageal or gastric cancer? Int J Colorectal Dis 20:89–93CrossRef
11.
go back to reference Ichikura T, Chochi K, Sugasawa H, Mochizuki H (2007) Proposal for a new definition of true cardia carcinoma. J Surg Oncol 95:561–566PubMedCrossRef Ichikura T, Chochi K, Sugasawa H, Mochizuki H (2007) Proposal for a new definition of true cardia carcinoma. J Surg Oncol 95:561–566PubMedCrossRef
12.
go back to reference Verdecchia ACI, Gatta G, Lisi D, Faivre J, Forman D, EUROCARE Working Group (2004) Explaining gastric cancer survival differences among European countries. Int J Cancer 109:737–741PubMedCrossRef Verdecchia ACI, Gatta G, Lisi D, Faivre J, Forman D, EUROCARE Working Group (2004) Explaining gastric cancer survival differences among European countries. Int J Cancer 109:737–741PubMedCrossRef
13.
go back to reference Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK (2006) Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia. Dig Surg 23:313–318PubMedCrossRef Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK (2006) Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia. Dig Surg 23:313–318PubMedCrossRef
14.
go back to reference Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M (2006) Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 30:1864–1869PubMedCrossRef Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M (2006) Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 30:1864–1869PubMedCrossRef
15.
go back to reference Sutter AP, Zeitz M, Scherubl H (2004) Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer. Onkologie 27:17–21 (see comment)PubMedCrossRef Sutter AP, Zeitz M, Scherubl H (2004) Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer. Onkologie 27:17–21 (see comment)PubMedCrossRef
16.
go back to reference Kretzschmar A, Schlag PM (2006) Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer? Zentralbl Chir 131:121–125PubMedCrossRef Kretzschmar A, Schlag PM (2006) Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer? Zentralbl Chir 131:121–125PubMedCrossRef
17.
go back to reference Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, carffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, carffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20PubMedCrossRef
18.
go back to reference Furukawa T, Fu X, Kubota T, Watanabe M, Kitajima M, Hoffman RM (1993) Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 53:1204–1208PubMed Furukawa T, Fu X, Kubota T, Watanabe M, Kitajima M, Hoffman RM (1993) Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res 53:1204–1208PubMed
19.
go back to reference Hotz HG, Reber HA, Hotz B, Yu T, Foitzik T, Buhr HJ, Cortina G, Hines OJ (2003) An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 26:e89–e98PubMedCrossRef Hotz HG, Reber HA, Hotz B, Yu T, Foitzik T, Buhr HJ, Cortina G, Hines OJ (2003) An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 26:e89–e98PubMedCrossRef
20.
21.
go back to reference Cronin-Fenton DP, Sharp L, Carsin AE, Comber H (2007) Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer 43:565–575PubMedCrossRef Cronin-Fenton DP, Sharp L, Carsin AE, Comber H (2007) Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. Eur J Cancer 43:565–575PubMedCrossRef
22.
go back to reference Valverde CM, Macarulla T, Casado E, Ramos FJ, Martinelli E, Tabernero J (2006) Novel targets in gastric and esophageal cancer. Crit Rev Oncol /hematol 59:128–138CrossRef Valverde CM, Macarulla T, Casado E, Ramos FJ, Martinelli E, Tabernero J (2006) Novel targets in gastric and esophageal cancer. Crit Rev Oncol /hematol 59:128–138CrossRef
23.
go back to reference Tabernero J, Macarulla T, Ramos FJ, Baselga J (2005) Novel targeted therapies in the treatment of gastric and esophageal cancer. Ann Oncol 16:1740–1748PubMedCrossRef Tabernero J, Macarulla T, Ramos FJ, Baselga J (2005) Novel targeted therapies in the treatment of gastric and esophageal cancer. Ann Oncol 16:1740–1748PubMedCrossRef
24.
go back to reference Saikawa Y, Kubota T, Kuo TH, Tanino H, Kase S, Furukawa T, Watanabe M, Ishibiki K, Kitajima M, Hoffman RM (1994) Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo. Anticancer Res 14:461–464PubMed Saikawa Y, Kubota T, Kuo TH, Tanino H, Kase S, Furukawa T, Watanabe M, Ishibiki K, Kitajima M, Hoffman RM (1994) Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo. Anticancer Res 14:461–464PubMed
25.
go back to reference Recchia F, Saggio G, Candeloro G, Cesta A, Amiconi G, Blasio AD, Necozione S, Rea S (2007) Chemoimmunotherapy in the treatment of metastatic gastric cancer. Anti-Cancer Drugs 18:597–604PubMedCrossRef Recchia F, Saggio G, Candeloro G, Cesta A, Amiconi G, Blasio AD, Necozione S, Rea S (2007) Chemoimmunotherapy in the treatment of metastatic gastric cancer. Anti-Cancer Drugs 18:597–604PubMedCrossRef
26.
go back to reference Liang DM, Chen JY, Zhang Y, Gan P, Lin J, Chen AB (2006) Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice. World J Gastroenterol 12:3810–3813PubMed Liang DM, Chen JY, Zhang Y, Gan P, Lin J, Chen AB (2006) Effects of recombinant human growth hormone on growth of human gastric carcinoma xenograft model in nude mice. World J Gastroenterol 12:3810–3813PubMed
27.
go back to reference Fujimoto-Ouchi K, Sekiguchi F, Yasuno H, Moriya Y, Mori K, Tanaka Y (2007) Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models. Cancer Chemother Pharmacol 59:795–805PubMedCrossRef Fujimoto-Ouchi K, Sekiguchi F, Yasuno H, Moriya Y, Mori K, Tanaka Y (2007) Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models. Cancer Chemother Pharmacol 59:795–805PubMedCrossRef
28.
go back to reference Koyama TTA, Nariai K, Mitsunaga M, Yanaga K, Takahashi H (2007) Novel biomedical imaging approach for detection of sentinel nodes in an experimental model of gastric cancer. Br J Surg 94:996–1001PubMedCrossRef Koyama TTA, Nariai K, Mitsunaga M, Yanaga K, Takahashi H (2007) Novel biomedical imaging approach for detection of sentinel nodes in an experimental model of gastric cancer. Br J Surg 94:996–1001PubMedCrossRef
29.
go back to reference Kerbel RS (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2:S134–S139PubMed Kerbel RS (2003) Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved. Cancer Biol Ther 2:S134–S139PubMed
30.
go back to reference Onn A, Isobe T, Itasaka S, Wu W, O’Reilly MS, Ki Hong W, Fidler IJ, Herbst RS (2003) Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 9:5532–5539PubMed Onn A, Isobe T, Itasaka S, Wu W, O’Reilly MS, Ki Hong W, Fidler IJ, Herbst RS (2003) Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Clin Cancer Res 9:5532–5539PubMed
31.
go back to reference Takahashi T, Morotomi M, Nomoto K (2004) A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells. Cancer Sci 95:514–519PubMedCrossRef Takahashi T, Morotomi M, Nomoto K (2004) A novel mouse model of rectal cancer established by orthotopic implantation of colon cancer cells. Cancer Sci 95:514–519PubMedCrossRef
32.
go back to reference Hotz HG, Reber HA, Hotz B, Foitzik T, Buhr HJ, Cortina G, Hines OJ (2001) An improved clinical model of orthotopic pancreatic cancer in immunocompetent Lewis rats. Pancreas 22:113–121PubMedCrossRef Hotz HG, Reber HA, Hotz B, Foitzik T, Buhr HJ, Cortina G, Hines OJ (2001) An improved clinical model of orthotopic pancreatic cancer in immunocompetent Lewis rats. Pancreas 22:113–121PubMedCrossRef
Metadata
Title
An orthotopic nude mouse model for preclinical research of gastric cardia cancer
Authors
Sarah Bhargava
Birgit Hotz
Heinz J. Buhr
Hubert G. Hotz
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
International Journal of Colorectal Disease / Issue 1/2009
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-008-0584-z

Other articles of this Issue 1/2009

International Journal of Colorectal Disease 1/2009 Go to the issue